Federal contract award

75F40124F19032

BPA CALL - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541820 — Public Relations Agencies
PSCB599 — Other Special Studies and Analysis
Parent award / vehicle75F40120A00018
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$217.7K
Current contract value$217.7K
Potential contract value / ceiling$217.7K
Start dateJul 25, 2024
Current end dateJun 20, 2025
Potential end dateJun 20, 2025
Latest award activityJul 27, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 27, 2026P00007$49.0KADD FUNDING THAT WAS PREVIOUSLY REMOVED
Jun 3, 2026P00006$0UPDATE PRISM WITH THE COR NAME ERRONEOUSLY OMITTED IN THE LAST MODIFICATION
May 19, 2026P00005$0BPA CALL - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.
Feb 4, 2026P00004$-427.3KSETTLEMENT OF THE FULL TERMINATION FOR CONVENIENCE OF THE GOVERNMENT - BPA TASK ORDER - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.
Jun 25, 2025P00003$0MOD P00001 - BPA CALL - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.
Jun 11, 2025P00002$0MOD P00001 - BPA CALL - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.
Mar 28, 2025P00001$8.4KMOD P00001 - BPA CALL - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.
Jul 25, 20240$587.5KBPA CALL - ADVERSE EVENT RATES IN DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION.

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.